- Home
- RLMD vs GNE Comparison
RLMD vs GNE Comparison
Compare RLMD & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLMD | GNE |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 319.0M | 382.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RLMD | GNE |
|---|---|---|
| Price | $4.38 | $13.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | ★ 978.5K | 108.5K |
| Earning Date | 11-13-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 2.18% |
| EPS Growth | N/A | ★ 49.43 |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $483,284,000.00 |
| Revenue This Year | N/A | $14.60 |
| Revenue Next Year | N/A | $8.64 |
| P/E Ratio | ★ N/A | $49.64 |
| Revenue Growth | N/A | ★ 13.12 |
| 52 Week Low | $0.24 | $13.05 |
| 52 Week High | $5.12 | $28.47 |
Technical Indicators
Market Signals| Indicator | RLMD | GNE |
|---|---|---|
| Relative Strength Index (RSI) | 53.35 | 41.51 |
| Support Level | $4.28 | $13.72 |
| Resistance Level | $4.75 | $14.06 |
| Average True Range (ATR) | 0.39 | 0.41 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 39.11 | 18.00 |
Price Performance
Historical ComparisonAbout RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About GNE Genie Energy Ltd. Class B Stock
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.